ArticleFEBS open bio2026
The C-terminal domain of yeast Arginyltransferase1 is essential for its catalytic activity.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Arginyltransferase 1 (Ate1), a conserved eukaryotic enzyme, has recently been structurally characterised; identifying a conserved N-terminal domain, a central GNAT fold and a variable C-terminal domain of unknown function. Here, using budding yeast as an experimental model, we established that the C-terminal domain is indispensable for Ate1 stability, its enzymatic activity and Ate1-mediated cell death. Furthermore, we found that the co-expression of separated N-terminal and C-terminal halves of Ate1 did not reconstitute enzyme activity in vivo. Also, we observed that the mutation of conserved residues involved in cofactor binding and active site formation within the N-terminal half of Ate1 abolishes the enzyme function. Moreover, we showed that mouse Ate1, when heterogeneously expressed in yeast, was catalytically active but not lethal. These findings underscore the structural interdependence of Ate1 domains and their integrity in maintaining enzyme catalytic activity and stability, providing deeper insights into the enzyme structure-function relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.